Deep Brain Stimulation Not Linked to Greater Risk of Dementia for Parkinson’s Patients, Study Concludes
Long-term deep brain stimulation (DBS) is cognitively safe and does not increase the risk for dementia in people with…
Patricia holds her PhD in cell biology from the University Nova de Lisboa, Portugal, and has served as an author on several research projects and fellowships, as well as major grant applications for European agencies. She also served as a PhD student research assistant in the Department of Microbiology & Immunology, Columbia University, New York, for which she was awarded a Luso-American Development Foundation (FLAD) fellowship.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Long-term deep brain stimulation (DBS) is cognitively safe and does not increase the risk for dementia in people with…
Ongentys (opicapone) has been approved in Japan as an oral, add-on daily treatment for Parkinson’s disease patients experiencing off periods while…
The University at Buffalo has received a $2.2 million grant from the National Institute of Neurological Disorders and…
Equfina (safinamide) has been approved in South Korea as an add-on therapy to levodopa for Parkinson’s disease patients who…
Structural changes within alpha-synuclein can make this protein more prone to clumping — a common feature of Parkinson’s — a…
Manus Neurodynamica, a medical technology company, has raised £750,000 in a financing round to support the rollout of…
The U.S. Food and Drug Administration (FDA) has agreed to review Adamas Pharmaceutical’s application asking that oral Gocovri (…
People carrying gene variants that lower leucine-rich repeat kinase 2 (LRRK2) levels — an enzyme whose mutated form is one of…
Seelos Therapeutics announced it is beginning, earlier than expected, a preclinical study into its investigational gene therapy candidate for Parkinson’s disease called…
Current or past tobacco smokers are at lower risk of developing Parkinson’s disease than lifelong non-smokers, a long-term study of doctors…
Get regular updates to your inbox.